Explore

Trendline Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches

Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches

Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Trendline Trendline
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
Trendline Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
Trendline Trendline
Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss

Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss

Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss
Trendline Trendline
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine

SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine

SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook
Trendline Trendline
GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook

GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook

GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook
Trendline Trendline
GeneDx Reports Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Q1 2026 Financial Results and Updates Outlook

GeneDx Reports Q1 2026 Financial Results and Updates Outlook
Trendline Trendline
IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance
Trendline Trendline
IQVIA Reports Strong Q1 2026 Results with Increased Revenue and Earnings

IQVIA Reports Strong Q1 2026 Results with Increased Revenue and Earnings

IQVIA Reports Strong Q1 2026 Results with Increased Revenue and Earnings
Trendline Trendline
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss

Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss

Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss